Harvest Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-395
| Closed | -$24K | – | 638 |
|
|
2025
Q1 | $24K | Sell |
395
-6,433
| -94% | -$391K | ﹤0.01% | 532 |
|
|
2024
Q4 | $386K | Buy |
6,828
+4,259
| +166% | +$241K | 0.02% | 371 |
|
|
2024
Q3 | $133K | Buy |
+2,569
| New | +$133K | 0.01% | 384 |
|
|
2023
Q3 | – | Sell |
-1,370
| Closed | -$88K | – | 643 |
|
|
2023
Q2 | $88K | Hold |
1,370
| – | – | 0.02% | 344 |
|
|
2023
Q1 | $95K | Sell |
1,370
-5,814
| -81% | -$403K | 0.02% | 345 |
|
|
2022
Q4 | $517K | Buy |
7,184
+3,569
| +99% | +$257K | 0.13% | 100 |
|
|
2022
Q3 | $257K | Buy |
3,615
+1,800
| +99% | +$128K | 0.07% | 152 |
|
|
2022
Q2 | $140K | Hold |
1,815
| – | – | 0.04% | 237 |
|
|
2022
Q1 | $132K | Hold |
1,815
| – | – | 0.03% | 293 |
|
|
2021
Q4 | $113K | Buy |
+1,815
| New | +$113K | 0.02% | 311 |
|
|
2021
Q2 | – | Sell |
-354
| Closed | -$22K | – | 776 |
|
|
2021
Q1 | $22K | Sell |
354
-1,472
| -81% | -$91.5K | ﹤0.01% | 620 |
|
|
2020
Q4 | $113K | Sell |
1,826
-550
| -23% | -$34K | 0.01% | 227 |
|
|
2020
Q3 | $140K | Sell |
2,376
-4,773
| -67% | -$281K | 0.01% | 216 |
|
|
2020
Q2 | $424K | Sell |
7,149
-5,845
| -45% | -$347K | 0.04% | 82 |
|
|
2020
Q1 | $723K | Buy |
12,994
+2,664
| +26% | +$148K | 0.08% | 48 |
|
|
2019
Q4 | $820K | Buy |
10,330
+5,744
| +125% | +$456K | 0.08% | 43 |
|
|
2019
Q3 | $233K | Buy |
+4,586
| New | +$233K | 0.03% | 105 |
|
|
2019
Q1 | – | Sell |
-3,522
| Closed | -$183K | – | 358 |
|
|
2018
Q4 | $183K | Hold |
3,522
| – | – | 0.04% | 122 |
|
|
2018
Q3 | $219K | Buy |
+3,522
| New | +$219K | 0.04% | 148 |
|